Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dickson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Paediatric Anaesthesia|May 13, 1999
The intravascular migration of an epidural catheterM A Dickson, E Doyle
Anaesthesia|July 1, 1994
Extension of epidural blockade for emergency caesarean section. Assessment of a bolus dose of bupivacaine 0.5% 10 ml following an infusion of 0.1% for analgesia in labourM A Dickson, J Jenkins
Current Oncology (Toronto, Ont.)|April 17, 2009
Development of cell-cycle inhibitors for cancer therapyM A Dickson, G K Schwartz
International Journal of Obstetric Anesthesia|October 1, 1994
Acute colonic pseudo-obstruction after caesarean sectionM A Dickson, J H McClure
British Journal of Anaesthesia|December 9, 1997
Comparison of single, end-holed and multi-orifice extradural catheters when used for continuous infusion of local anaesthetic during labourM A Dickson, C Moores, J H McClure
Oncology Nursing Forum|April 24, 1999
A resource kit for women with breast cancer: development and evaluationN Samarel, J Fawcett, L Tulman, et al.
British Journal of Cancer|May 26, 2011
Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)G K Schwartz, P M LoRusso, M A Dickson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
Molecular and Cellular Biology|January 29, 2000
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristicsM A Dickson, W C Hahn, Y Ino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Paediatric Anaesthesia|May 13, 1999
The intravascular migration of an epidural catheterM A Dickson, E Doyle
Anaesthesia|July 1, 1994
Extension of epidural blockade for emergency caesarean section. Assessment of a bolus dose of bupivacaine 0.5% 10 ml following an infusion of 0.1% for analgesia in labourM A Dickson, J Jenkins
Current Oncology (Toronto, Ont.)|April 17, 2009
Development of cell-cycle inhibitors for cancer therapyM A Dickson, G K Schwartz
International Journal of Obstetric Anesthesia|October 1, 1994
Acute colonic pseudo-obstruction after caesarean sectionM A Dickson, J H McClure
British Journal of Anaesthesia|December 9, 1997
Comparison of single, end-holed and multi-orifice extradural catheters when used for continuous infusion of local anaesthetic during labourM A Dickson, C Moores, J H McClure
Oncology Nursing Forum|April 24, 1999
A resource kit for women with breast cancer: development and evaluationN Samarel, J Fawcett, L Tulman, et al.
British Journal of Cancer|May 26, 2011
Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)G K Schwartz, P M LoRusso, M A Dickson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
Molecular and Cellular Biology|January 29, 2000
Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristicsM A Dickson, W C Hahn, Y Ino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.
Pageof 2